JPH07503475A - ベラパミルのラセミ分割法 - Google Patents
ベラパミルのラセミ分割法Info
- Publication number
- JPH07503475A JPH07503475A JP5513716A JP51371693A JPH07503475A JP H07503475 A JPH07503475 A JP H07503475A JP 5513716 A JP5513716 A JP 5513716A JP 51371693 A JP51371693 A JP 51371693A JP H07503475 A JPH07503475 A JP H07503475A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- verapamil
- racemic resolution
- optically active
- racemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 title claims description 17
- 229960001722 verapamil Drugs 0.000 title claims description 17
- 239000002253 acid Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 239000012458 free base Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 230000004888 barrier function Effects 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229960001367 tartaric acid Drugs 0.000 description 5
- 239000011975 tartaric acid Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- SGTNSNPWRIOYBX-MHZLTWQESA-N (S)-verapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-MHZLTWQESA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DOQPXTMNIUCOSY-UHFFFAOYSA-N [4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-methylazanium;chloride Chemical compound [H+].[Cl-].C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 DOQPXTMNIUCOSY-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960000881 verapamil hydrochloride Drugs 0.000 description 2
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 1
- OCQAXYHNMWVLRH-UHFFFAOYSA-N 2,3-dibenzoyl-2,3-dihydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(O)(C(O)=O)C(O)(C(=O)O)C(=O)C1=CC=CC=C1 OCQAXYHNMWVLRH-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- XQLWNAFCTODIRK-UHFFFAOYSA-N Gallopamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C(OC)=C1 XQLWNAFCTODIRK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002807 Thiomer Polymers 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SGTNSNPWRIOYBX-HHHXNRCGSA-N dexverapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC[C@@](C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-HHHXNRCGSA-N 0.000 description 1
- NTBIYBAYFBNTCD-KBPBESRZSA-N dibenzoyl (2s,3s)-2,3-dihydroxybutanedioate Chemical compound O=C([C@@H](O)[C@H](O)C(=O)OC(=O)C=1C=CC=CC=1)OC(=O)C1=CC=CC=C1 NTBIYBAYFBNTCD-KBPBESRZSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229960000457 gallopamil Drugs 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/32—Separation; Purification; Stabilisation; Use of additives
- C07C253/34—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Electrotherapy Devices (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
Claims (3)
- 1.ベラパミルのラセミ分割方法において、この化合物の遊離塩基を、光学活性 のジベンゾイル酒石酸又はジトルオイル酒石酸と、モル比1:1〜1:2で、1 :1〜3:1の比のメタノール−水−混合物又は0.5:1〜2:1の比のアセ トン−水−混合物中で、反応させ、こうして得たジアステレオマー混合物を、結 晶化により分離し、その後、このジアステレオマーを遊離塩基に変え、かつ、場 合により生理学的に認容性の酸を用いて、その垣に変えることを、特徴とする、 ベラパミルのラセミ分割法。
- 2.光学活性のジベンゾイル酒石酸又はジトルオイル酒石酸の50%までを、塩 酸と交換する、請求項1に記載の方法。
- 3.ベラパミルと、光学活性のジベンゾイル酒石酸又はジトルオイル酒石酸とを 、モル比1:0.75で、塩酸0.5モルの存在で、反応させる、請求項1に記 載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4203547A DE4203547A1 (de) | 1992-02-07 | 1992-02-07 | Verfahren zur racemattrennung von verapamil |
DE4203547.3 | 1992-02-07 | ||
PCT/EP1993/000196 WO1993016035A1 (de) | 1992-02-07 | 1993-01-28 | Verfahren zur racemattrennung von verapamil |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07503475A true JPH07503475A (ja) | 1995-04-13 |
JP3307641B2 JP3307641B2 (ja) | 2002-07-24 |
Family
ID=6451183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51371693A Expired - Lifetime JP3307641B2 (ja) | 1992-02-07 | 1993-01-28 | ベラパミルのラセミ分割法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5457224A (ja) |
EP (1) | EP0625137B1 (ja) |
JP (1) | JP3307641B2 (ja) |
AT (1) | ATE151413T1 (ja) |
CA (1) | CA2122254C (ja) |
DE (2) | DE4203547A1 (ja) |
DK (1) | DK0625137T3 (ja) |
ES (1) | ES2099421T3 (ja) |
MX (1) | MX9300473A (ja) |
WO (1) | WO1993016035A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007538022A (ja) * | 2004-05-18 | 2007-12-27 | エフ.ホフマン−ラ ロシュ アーゲー | 新規cis−イミダゾリン |
JP2008502620A (ja) * | 2004-06-17 | 2008-01-31 | エフ.ホフマン−ラ ロシュ アーゲー | 新規シスイミダゾリン |
JP2009541231A (ja) * | 2006-06-19 | 2009-11-26 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 多形および方法 |
JP2017533911A (ja) * | 2014-10-29 | 2017-11-16 | センター ラボラトリーズ, インク.Center Laboratories, Inc. | ベラパミル塩酸塩の結晶型 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9319918D0 (en) * | 1993-09-27 | 1993-11-10 | Chiros Ltd | Chiral compounds and their preparation |
US5910601A (en) * | 1994-09-26 | 1999-06-08 | Darwin Discovery Limited | Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues |
DE19502967A1 (de) * | 1995-01-31 | 1996-08-01 | Basf Ag | Verfahren zur Racemattrennung von 2-Aryl-2-omega-alkylaminoalkannitrilen |
WO1997044025A1 (en) * | 1996-05-23 | 1997-11-27 | G.D. Searle & Co. | Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil |
GB9616549D0 (en) * | 1996-08-06 | 1996-09-25 | Chiroscience Ltd | Therapeutic product and its use |
KR100341256B1 (ko) * | 1999-09-11 | 2002-06-21 | 박호군 | 리파제를 이용한 베라파밀 중간체의 분할 및 (r)- 및 (s)-베라파밀의 제조 방법 |
US7863273B2 (en) | 2006-01-17 | 2011-01-04 | Glenmark Generics Ltd. | Process for the preparation of an optically active 5H-pyrrolo [3,4-B] pyrazine derivative |
ITMI20071160A1 (it) * | 2007-06-07 | 2008-12-08 | Cosma S P A | Procedimento di risoluzione del verapamil |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1154810B (de) * | 1961-04-01 | 1963-09-26 | Knoll Ag | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
DE2059923C3 (de) * | 1970-12-05 | 1979-01-25 | Knoll Ag, 6700 Ludwigshafen | l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel |
DE2946545A1 (de) * | 1979-11-17 | 1981-05-27 | Basf Ag, 6700 Ludwigshafen | Verfahren zur gewinnung der enantiomeren formen von 4-cyan-1-(n-methyl-n-(2'-((3'',4'',-dimethoxyphenyl))-aethyl)-amino)-5-methyl-4-(3',4',5'-trimethoxyphenyl)-hexan und dessen salzen |
DE3723684A1 (de) * | 1987-07-17 | 1989-01-26 | Basf Ag | Verfahren zur herstellung der enantiomeren von verapamil |
-
1992
- 1992-02-07 DE DE4203547A patent/DE4203547A1/de not_active Withdrawn
-
1993
- 1993-01-09 US US08/244,681 patent/US5457224A/en not_active Expired - Lifetime
- 1993-01-28 MX MX9300473A patent/MX9300473A/es unknown
- 1993-01-28 WO PCT/EP1993/000196 patent/WO1993016035A1/de active IP Right Grant
- 1993-01-28 DK DK93903886.5T patent/DK0625137T3/da active
- 1993-01-28 JP JP51371693A patent/JP3307641B2/ja not_active Expired - Lifetime
- 1993-01-28 EP EP93903886A patent/EP0625137B1/de not_active Expired - Lifetime
- 1993-01-28 CA CA002122254A patent/CA2122254C/en not_active Expired - Lifetime
- 1993-01-28 AT AT93903886T patent/ATE151413T1/de active
- 1993-01-28 DE DE59306121T patent/DE59306121D1/de not_active Expired - Lifetime
- 1993-01-28 ES ES93903886T patent/ES2099421T3/es not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007538022A (ja) * | 2004-05-18 | 2007-12-27 | エフ.ホフマン−ラ ロシュ アーゲー | 新規cis−イミダゾリン |
JP4814228B2 (ja) * | 2004-05-18 | 2011-11-16 | エフ.ホフマン−ラ ロシュ アーゲー | 新規cis−イミダゾリン |
JP2008502620A (ja) * | 2004-06-17 | 2008-01-31 | エフ.ホフマン−ラ ロシュ アーゲー | 新規シスイミダゾリン |
JP4809336B2 (ja) * | 2004-06-17 | 2011-11-09 | エフ.ホフマン−ラ ロシュ アーゲー | 新規シスイミダゾリン |
JP2009541231A (ja) * | 2006-06-19 | 2009-11-26 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 多形および方法 |
JP2017533911A (ja) * | 2014-10-29 | 2017-11-16 | センター ラボラトリーズ, インク.Center Laboratories, Inc. | ベラパミル塩酸塩の結晶型 |
Also Published As
Publication number | Publication date |
---|---|
EP0625137A1 (de) | 1994-11-23 |
US5457224A (en) | 1995-10-10 |
DE59306121D1 (de) | 1997-05-15 |
DE4203547A1 (de) | 1993-08-12 |
WO1993016035A1 (de) | 1993-08-19 |
ES2099421T3 (es) | 1997-05-16 |
CA2122254C (en) | 2004-05-18 |
DK0625137T3 (da) | 1997-05-05 |
CA2122254A1 (en) | 1993-08-19 |
MX9300473A (es) | 1993-09-01 |
ATE151413T1 (de) | 1997-04-15 |
EP0625137B1 (de) | 1997-04-09 |
JP3307641B2 (ja) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07503475A (ja) | ベラパミルのラセミ分割法 | |
ES2218799T3 (es) | Resolucion de sal de acido ritalinico. | |
JP3911545B2 (ja) | レボブピバカインとその類似体の晶出 | |
PT828702E (pt) | Processo para a resolucao de acidos quirais com 1-aminoindan-2-ois | |
ES2320012T3 (es) | Procedimientos y productos intermediarios para la preparacion de estereo-isomeros de piperidina 2-sustituida. | |
WO2016038422A1 (en) | Process for the preparation of optically enriched adrenaline | |
JP2009535327A (ja) | ロピバカイン塩酸塩無水物およびその調製 | |
JPS6152812B2 (ja) | ||
ES2284078T3 (es) | Procedimiento para la redisolucion de nefopam. | |
JPS5982365A (ja) | 新規なラセミ分割ケト化合物およびその製法 | |
JP2884703B2 (ja) | 光学活性2―メチルピペラジンの製造法 | |
US20200131126A1 (en) | Process for the Separation of Optical Isomers of Racemic 3-Alkylpiperidine-Carboxylic Acid Ethyl Esters | |
EP1988086B2 (en) | Process for resolving citalopram via its (S)-enriched citalopram tartrate compound. | |
EP1224161B1 (en) | Nitroxy derivatives of (r) and (s)-carnitine | |
KR20010079913A (ko) | (-)-α-(디플루오로메틸)오르니틴-모노히드로클로라이드일수화물의 제조 방법 | |
JPH02306942A (ja) | 光学活性フェニルエチルアミン誘導体の製造法 | |
JP2574254B2 (ja) | 光学分割法 | |
ES2385975T3 (es) | Procedimiento para la preparación de citalopram diol racémico y/o S- O R-citalopram dioles y el uso de tales dioles para la preparación de citalopram racémico, R-citalopram y/o S-citalopram | |
JP2712669B2 (ja) | 光学活性1,2―プロパンジアミンの製法 | |
JP2616211B2 (ja) | 光学活性1,2―プロパンジアミンの製法 | |
JPS59176260A (ja) | 8−アミノ−2−メチル−4−フエニル−1,2,3,4−テトラヒドロイソキノリンの光学対掌体 | |
JPS62123156A (ja) | 光学活性エリトロ―2―アミノ―1,2―ジフェニルエタノールの製造方法および製造の中間体 | |
JPH0470304B2 (ja) | ||
JPS61134344A (ja) | (±)−2−フエニルプロピオン酸および/または(±)−2−フエネチルアミンの光学分割法 | |
JPS58124749A (ja) | (±)−エリトロ−2−アミノ−1,2−ジフェニルエタノ−ルの光学分割法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090517 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100517 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100517 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110517 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120517 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130517 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130517 Year of fee payment: 11 |